Daily Trade

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment. The European approval of Regdanvimab, marketed by Celltrion as Regkirona in South Korea, drop up the company’s stock price 068270, +9.60% as much as 18% to 251,000 Korean won ($212.72) after the news
0 Comments
Dear MarketWatch, I am 49 years old (turning 50 this year) and my wife is 34. We have two young children under the age of 2, and twin girls, age 11, from my prior marriage. College for the twins is fully funded in a 529 plan and I save monthly in 529 plans for my
0 Comments
With cryptocurrencies posting blistering performances recently, those on the sidelines are increasingly tempted to jump in. At the same time, direct exposure to individual blockchain coins and tokens has its own set of risks outside of market volatility. For an alternative, many have turned to crypto miners like Stronghold Digital Mining (NASDAQ:SDIG) stock. Source: Mark
0 Comments
When Elon Musk polled his Twitter followers over the weekend about whether or not he should sell his Tesla stock, it might have seemed like the typical oddball move for the billionaire entrepreneur. But financial professionals said Musk’s tweet was possibly driven by the desire to employ a smart, end-of-year tax strategy. And they note
0 Comments
Earlier this year, trading shares of New York-based virtual content provider fuboTV (NYSE:FUBO) was a risky proposition. The price action of FUBO stock was like a roller-coaster ride, and not ideal for cautious investors. Source: Lori Butcher/ShutterStock.com However, moving into the last two months of 2021, the situation seemed much calmer … until the pain from
0 Comments
First, there was the meme token known as Dogecoin (CCC:DOGE-USD). Then came Shiba Inu (CCC:SHIB-USD), which actually managed to overtake Dogecoin in popularity. Yet, there’s a third canine-themed coin, Floki Inu (CCC:FLOKI-USD), and I don’t recommend dismissing Floki Inu as an also-ran. Source: Wit Olszewski I’ll admit that as an old-school, fundamentals-focused investor, I had difficulty taking any
0 Comments
How many years of lagging stock portfolio returns would you tolerate in order to avoid the bursting of a stock market bubble? That in effect is what Wall Street’s “permabears” are asking. They’ve been bearish on U.S. stocks for a number of years now, and therefore they (and their clients) have missed out on one
0 Comments
Shares of Walt Disney Co. dove toward an 11-month low Thursday, as multiple analysts cut price their price targets, even the bullish ones, in response to the media and theme-park giant’s disappointing earnings and outlook for Disney+ subscribers. But Wall Street remained overwhelmingly bullish on Disney’s prospects, highlighting the expected continued rebounds in the company’s
0 Comments
Gores Guggenheim (NASDAQ:GGPI) is the latest SPAC (Special Purpose Acquisition Company) stock to start revving its carbon-free engine. The blank check company completed its initial public offering (IPO) in March and announced its reverse merger with Electric Vehicle (EV) maker Polestar in September. GGPI shares are now trading at a roughly 7% premium to trust
0 Comments
Planning a trip to visit family for the holidays this year? You won’t be alone — and that makes the potential for widespread flight delays and cancellations all the more likely. With nearly 200 million Americans vaccinated against the virus that causes COVID-19 and the delta variant receding, many more people are feeling comfortable taking
0 Comments
It’s no shock Greenidge Generation (NASDAQ:GREE) has been bouncing back lately. After all, bullish sentiment is returning to GREE stock now that Bitcoin (CCC:BTC-USD), the crypto it mines, is up near all-time highs. But there’s also a longer-term catalyst that GREE fans have high hopes about: Its expansion plans. Source: Mark Agnor / Shutterstock.com GREE’s latest success
0 Comments